Site Map Press Room Careers
Financial
Financial Results
Financial Highlights
Annual Reports
Business Drivers
Investors
Contact Person
Frequently Asked Questions
 Financial Results
Audited Financial Results for the Year ended 31st March, 2005
  (Rs.in Mio)

Particulars

 Unaudited Results Audited Results Consolidated Results
Nine Months Ended Three Months Ended The Year Ended The Year Ended
31.12.2004 31.03.2005 31.03.2004 31.03.2005 31.03.2004 31.03.2005 31.03.2004
Net Sales/Income from Operations 8735.7 2856.0 3630.7 11591.7 13410.7 14167.3 15869.1
Other Income 90.4 75.2 83.8 165.6 220.6 176.9 282.4
Total income 8826.1 2931.2 3714.5 11757.3 13631.3 14344.2 16151.5
Expenditure

 

            
a. (Increase)/Decrease in Stock in Trade (128.1) (4.3) (20.6) (132.4) (363.5) (26.7) (415.2))
b. Consumption of Raw Material 4851.5 1722.9 1901.8 6574.4 7870.7 7694.2 9017.9
c. Staff Cost 525.6 136.7 141.7 662.3 513.5 902.0 715.9
d. Other Expenditure 2521.7 897.4 977.1 3419.1 3221.3 4448.4 4337.7
Total expenditure 7770.7 2752.7 3041.2 10523.4 11242.0 13017.9 13656.3
Profit before depreciation, interest & tax 1055.4 178.5 673.3 1233.9 2389.3 1326.3 2495.2
Interest 279.6 120.3 84.8 399.9 322.5 496.5 407.3
Depreciation 358.0 46.9 96.1 404.9 341.6 646.7 562.3
Profit before taxation 417.8 11.3 492.4 429.1 1725.2 183.1 1525.6
Provision for Taxation              
a. Current Tax 34.7 5.4 80.6 40.1 292.7 81.3 303.3
b. Deferred Tax 69.6 (30.8) 48.8 38.8 161.5 49.5 151.1
c. Tax adjustments of previous years 1.8 (2.3) 0.8 (0.5) 0.8 (0.5) 0.8
Net Profit 311.7 39.0 362.2 350.7 1270.2 52.8 1068.4
Paid-up Equity Share Capital (Face value Rs. 5 per share) 253.9 253.9 253.9 253.9 253.9 253.9 253.9
Reserves excluding Revaluation Reserve       7632.0 7309.9 6508.4 6637.9
Basic Earnings per share (Rs.) (not annualised) 6.14 0.77 7.31 6.91 26.54 0.64 22.16
Diluted Earnings per share (Rs.) 6.14 0.77 7.31 6.91 26.41 0.64 22.05
Aggregate of non-promoters Shareholding              
a. Number of Shares       22939156 22942230    
b. Percentage of Shareholding       45.18 45.19    
Notes:
1. >The above audited Quarterly Results as reviewed by the Audit Committee have been taken on record by the Board at its meeting held on June 30, 2005.
2. Investor  complaints  pending  at  the  beginning   of  the  fourth quarter: Nil,  received: 110,   resolved: 110 and  lying  unresolved at the end of the quarter: Nil.
3. The consolidated Quarterly Results include the results of subsidiary companies and joint venture companies as per Accounting Standard 21& 27.
4. The Board recommends dividend @10%on the equity share capital of the Company i.e Rs.0.50 per share subject to approval of members.
5. The Company's equity shares have been delisted from the Ahmedabad and Madras Stock Exchanges with effect from 15th January 2004 and 26th February 2004 respectively. The shares now continue to be listed on Hyderabad, Bomaby and National Stock Exchanges.
6. Keeping in view the Company's business model of vertical integration, the management reviewed the reporting of its  financial  results  under  one segment and accordingly the Company reported its entire results under one segment viz. 'Pharmaceutical Products'.
7. F.O.B value of exports is Rs.5546.2 millions (previous year Rs.6420.4 millions).
8. Figures have been regrouped wherever necessary.
    For and on behalf of the Board
Place: Hyderabad    K.Nityananda Reddy
Date : June 30, 2005   Managing Director
Site Map Press Room Careers